electroCore Inc. (NASDAQ: ECOR) Starts Presentation at The LD 500
electroCore Inc. (NASDAQ: ECOR) is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation (nVNS) therapy, which is initially focused on the treatment of multiple conditions in neurology. The company's current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. electroCore has secured an extensive intellectual property portfolio, with more than 200 patents and patent applications worldwide. These patents and patent applications cover many critical areas of its technology, including the proprietary signal, methods of treatment, non-invasive delivery means and mechanisms of…







